Indeed IGF2BP2 modulates cellular metabolism in human metabolic diseases such as diabetes, obesity and fatty liver through post-transcriptional regulation of numerous genes in multiple cell types. This evidence concerns the gene IGF2BP2 and obesity due to melanocortin 4 receptor deficiency.